Brief: Chemometec Hikes FY 2024/25 Revenue, EBITDA Guidance
Dec 3 (Reuters) - Chemometec A/S CHEMM.CO :
* REPORTS BETTER-THAN-EXPECTED SALES AND ORDER INTAKE IN Q2
2024/25
* NOW EXPECTS REVENUE FOR 2024/25 FINANCIAL YEAR IN DKK
460-475
MILLION RANGE
* SEES 2024/25 EBITDA IN DKK 230-240 MILLION RANGE
* PREVIOUS FY REVENUE GUIDANCE DKK 445-460 MILLION
* PREVIOUS FY EBITDA GUIDANCE DKK 222-230 MILLION
Source text: ID:nGNE4sNqgd
Further company coverage: CHEMM.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation